We take pride in our approach to integrated research, education, and clinical care. It enables us to deliver the most advanced treatments and technologies to patients. We are seeing faster progress in treatment areas and the adoption of new tools for cancer screening and prevention, which are transforming lives in Iowa and beyond.

Bri O’Leary, PhD, in the Joseph Cullen lab on Tuesday, Dec. 17, 2024.

Iowa’s only

NCI-designated Comprehensive Cancer Center
Marion Vanneste, postdoctoral research scholar in the Department of Molecular Physiology and Biophysics on Friday, Dec. 2, 2022.

290 +

Members
Exterior of Holden Comprehensive Cancer Center with new brand campaign display at University of Iowa Health Care’s university campus on Tuesday, July 22, 2025.

200 +

clinical research trials open

Latest Holden News

James Howe, MD, Receives NANETS Lifetime Achievement Award

James Howe, MD, Receives NANETS Lifetime Achievement Award

Wednesday, November 18, 2026
James Howe, MD, professor of surgery and director of Surgical Oncology and Endocrine Surgery at University of Iowa Health Care, has been named the recipient of the 2026 Lifetime Achievement Award from the North American Neuroendocrine Tumor Society (NANETS).
Portrait of Mark Burkard, MD, PhD.

Better care, more hope for Iowans facing cancer

Friday, October 23, 2026
Mark Burkard, MD, PhD, is building on decades of progress in cancer research to bring together innovation and statewide expertise to change what’s possible for Iowans facing cancer.
Kolesar and team

FDA Greenlights Clinical Trials for College of Pharmacy Ovarian Cancer Research

Friday, October 2, 2026
The FDA has cleared Dean Jill Kolesar's novel ovarian cancer therapy for human clinical trials, using extracellular vesicles to turn tumor-supporting immune cells into tumor-killing ones.

Support our research and programs

Your gift will help to advance our mission of advancing cancer medical research.